Steno Diabetes Center Copenhagen
Herlev, 2730, Denmark
Location contact
Kirsten Norgaard, Professor
SUB_INVESTIGATOR
Merete Christensen, MD, PhD
CONTACT
Merete Christensen, MD, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07474155
Automated insulin delivery systems, also known as closed-loop systems, have shown to improve TIR, TAR, and TBR compared with insulin pump and CGM systems that cannot automatically dose insulin. Only few studies have described long-term use of AID systems over several years. Real-world studies suggest that the beneficial effects of AID systems on glycemic outcomes are sustained over time; however, a modest increase in body weight has been observed in some users, raising concerns about the metabolic trade-offs of improved glycemia. We aim to explore wether the improvements in glycemic outcomes and treatment satisfaction achieved with AID systems remain stable over multiple years, and secondly, if long-term treatment with AID systems may be associated with an increase in body weight.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Herlev, 2730, Denmark
Kirsten Norgaard, Professor
SUB_INVESTIGATOR
Merete Christensen, MD, PhD
CONTACT
Merete Christensen, MD, PhD
PRINCIPAL_INVESTIGATOR
40 participants, who have completed the Steno780G trial, will be invited to attend a follow-up visit at Steno Diabetes Center Copenhagen between 3.5 - 4.5 years after start of AID treatment to assess the long-term effects of the MiniMed 780G system.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Long term follow-up
Time frame: Last 2 weeks compared with 2 weeks before 780G start
Time frame: Last 2 weeks compared with 2 weeks before 780G start
Time frame: Compared with HbA1c before 780G
Time frame: Compared with bodyweight before 780G start
Time frame: Last 2 weeks compared with 2 weeks before 780G start
Time frame: last 2 weeks compared with 2 weeks before 780G start
Time frame: compared with DTQS before 780G start
Time frame: Compared with before 780G start
Time frame: compared with before 780G start
Contact information is provided by the study sponsor or research team.
Steno Diabetes Center Copenhagen
Other
Advanced Hybrid Closed-Loop Treatment in Adults With Type 1 Diabetes Not Meeting Glycaemic Targets - The Steno780G Follow-up Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739342
Autoimmune Diseases, Diabetes Mellitus
Rosedale, Auckland, New Zealand
View Trial DetailsNCT07670572
Activity, Autoimmune Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07706803
Autoimmune Diseases, Diabetes Mellitus
Los Angeles, California, United States
View Trial DetailsNCT07695727
Autoimmune Diseases, Autoimmunity
Milan, Italy
View Trial Details